| |
(18)
|
Net Income Per Share
|
The following table reflects net income (numerator) and average shares outstanding (denominator) for basic and diluted net income per share computations:
| |
|
Three months ended
|
|
|
Six months ended
|
|
| |
|
June 30,
|
|
|
June 30,
|
|
|
(in thousands, except per share data)
|
|
2025
|
|
|
2024
|
|
|
2025
|
|
|
2024
|
|
|
Net income
|
|
$ |
34,024 |
|
|
$ |
27,598 |
|
|
$ |
67,295 |
|
|
$ |
53,485 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding - basic
|
|
|
29,364 |
|
|
|
29,283 |
|
|
|
29,356 |
|
|
|
29,267 |
|
|
Dilutive securities
|
|
|
141 |
|
|
|
100 |
|
|
|
147 |
|
|
|
105 |
|
|
Weighted average shares outstanding- diluted
|
|
|
29,505 |
|
|
|
29,383 |
|
|
|
29,503 |
|
|
|
29,372 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share - basic
|
|
$ |
1.16 |
|
|
$ |
0.94 |
|
|
$ |
2.29 |
|
|
$ |
1.83 |
|
|
Net income per share - diluted
|
|
|
1.15 |
|
|
|
0.94 |
|
|
|
2.28 |
|
|
|
1.82 |
|
Certain SARs that were excluded from the EPS calculation because their impact was antidilutive were as follows:
| |
|
Three months ended
|
|
|
Six months ended
|
|
|
(shares in thousands)
|
|
June 30,
|
|
|
June 30,
|
|
| |
|
2025
|
|
|
2024
|
|
|
2025
|
|
|
2024
|
|
|
Antidilutive SARs
|
|
|
26 |
|
|
|
136 |
|
|
|
20 |
|
|
|
125 |
|
|